Yeleswaram Krishnaswamy
Rapport Therapeutics, Inc. Common Stock · Chief Development Officer
Yeleswaram Krishnaswamy is listed in filings as Chief Development Officer at Rapport Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through Apr 21, 2026, including sale activity. Recent filings connect the profile to Rapport Therapeutics, Inc. Common Stock (RAPP). The current snapshot covers public activity from Feb 4, 2025 to Apr 21, 2026. Reported amounts are shown as $1.8M to $3.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $85k2.8k shares | SellDec 31, 2025 | $30.05 | $39.51 | |
| $303k10.1k shares | SellMar 25, 2026 | $29.99 | $39.51 | |
| $13k360 shares | SellApr 8, 2026 | $34.90 | $39.51 | |
| $358k10.2k shares | SellApr 14, 2026 | $35.08 | $39.51 | |
| $321k9.2k shares | SellApr 13, 2026 | $34.97 | $39.51 | |
| $17k500 shares | SellApr 10, 2026 | $34.98 | $39.51 |